²Î¿¼ÎÄÏ×/References:
£Û1£Ý¡¡JELUSIC M,SESTAN M.IgA vasculitis or Henoch-Sch¢‰nlein purpura:genetics and beyond£ÛJ£Ý.Pediatr Nephrol,2021,36(8):2149-2153.
£Û2£Ý¡¡JANG H M,BAEK H,HAN M H,et al.Activation of complement system in Henoch-Sch¢‰nlein purpura nephritis£ÛJ£Ý.Fetal Pediatr Pathol,2022,41(1):29-36.
£Û3£Ý¡¡LEUNG A K C,BARANKIN B,LEONG K F.Henoch-Sch¢‰nlein purpura in children:an updated review£ÛJ£Ý.Curr Pediatr Rev,2020,16(4):265-276.
£Û4£Ý¡¡KURT-ÿðþ‰C ¦aK¦aR E D,SEKAR T,TULLUS K.Biopsy-proven Henoch-Sch¢‰nlein purpura nephritis:a single center experience£ÛJ£Ý.Pediatr Nephrol,2021,36(5):1207-1215.
£Û5£Ý¡¡ºúÑÇÃÀ,½ÔØ·¼.ÖÌÄʵÓöù¿Æѧ£ÛM£Ý.7°æ.±±¾©:ÈËÃñÎÀÉú³ö°æÉç,2005:1190-1200.
HU Y M,JIANG Z F.Zhu Futang practical pediatrics£ÛM£Ý.7th ed.Beijing:People¡äs Medical Publishing House,2005:1190-1200.
£Û6£Ý¡¡ÖлªÒ½Ñ§»á¶ù¿Æѧ·Ö»áÉöÔàѧ×é.×Ïñ°ÐÔÉöÑ×ÕïÖÎÑÖ¤Ö¸ÄÏ(2016)£ÛJ£Ý.Öлª¶ù¿ÆÔÓÖ¾,2017,55(9):647-651.
THE SUBSPECIALTY GROUP OF RENAL DISEASES,THE SOCIETY OF PEDIATRICS,CHINESE MEDICAL ASSOCIATION.Evidence-based guidelines for diagnosis and treatment of Henoch-Schonlein purpura nephritis (2016)£ÛJ£Ý.Chin J Pediatr,2017,55(9):647-651.
£Û7£Ý¡¡DELBET J D,PARMENTIER C,HERBEZ REA C,et al.Management of IgA vasculitis with nephritis£ÛJ£Ý.Paediatr Drugs,2021,23(5):425-435.
£Û8£Ý¡¡HASTINGS M C,RIZK D V,KIRYLUK K,et al.IgA vasculitis with nephritis:update of pathogenesis with clinical implications£ÛJ£Ý.Pediatr Nephrol,2022,37(4):719-733.
£Û9£Ý¡¡KIM W K,KIM C J,YANG E M.Risk factors for renal involvement in Henoch-Sch¢‰nlein purpura£ÛJ£Ý.J Pediatr (Rio J),2021,97(6):646-650.
£Û10£Ý¡¡LIU C,LUO L,FU M,et al.Analysis of children with Henoch-Schonlein purpura secondary to infection£ÛJ£Ý.Clin Rheumatol,2022,41(3):803-810.
£Û11£Ý¡¡SONG Y R,GUO W L,SHENG M,et al.Risk factors associated with renal crescentic formation in pediatric Henoch-Sch¢‰nlein purpura nephritis:a retrospective cohort study£ÛJ£Ý.BMC Pediatr,2020,20(1):501.
£Û12£Ý¡¡SU Q,JIANG L,CHAI J,et al.Changes of peripheral blood lymphocyte subsets and immune function in children with Henoch-Schonlein purpura nephritis£ÛJ£Ý.Iran J Immunol,2021,18(3):259- 267.
£Û13£Ý¡¡WU H,ZHANG P,LU M,et al.Henoch-Sch¢‰nlein purpura nephritis and cerebral venous sinus thrombosis due to hereditary deficiency of antithrombin III£ÛJ£Ý.Indian J Pediatr,2020,87(2):163-164.
£Û14£Ý¡¡DEMIR S,KAPLAN O,CELEBIER M,et al.Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis£ÛJ£Ý.Semin Arthritis Rheum,2020,50(6):1238-1244.
£Û15£Ý¡¡À,Ðì´ïÁ¼,ÖìÓ±.¶ùͯ¹ýÃôÐÔ×Ïñ°ÐÔÉöÑײ¡ÀíÌص㼰¢òb¼¶ÒÔÉÏΣÏÕÒòËØ·ÖÎö£ÛJ£Ý.°²»ÕÒ½Ò©,2022,26(5):895-899.
LI J,XU D L,ZHU Y.Pathological characteristics of children with Henoch-Schonlein purpura nephritis and analysis of risk factors above grade ¢òb£ÛJ£Ý.J Anhui Med,2019,26(5):895-899.
£Û16£Ý¡¡TAKISAWA S,TAKINO Y,LEE J,et al.Vitamin C is essential for the maintenance of skeletal muscle functions£ÛJ£Ý.Biology (Basel),2022,11(7):955.
£Û17£Ý¡¡ROGERS D R,LAWLOR D J,MOELLER J L.Vitamin C supplementation and athletic performance:a review£ÛJ£Ý.Curr Sports Med Rep,2023,22(7):255-259.
£Û18£Ý¡¡è¢À°ºì,ÕÔÀöÔÆ,·¿ºìÜ¿,µÈ.2016-2017ÄêÖйú12¡«17Ëê¶ùͯÇàÉÙÄêÉÅʳ΢Á¿ÓªÑøËØÉãÈë×´¿ö£ÛJ£Ý.ÎÀÉúÑо¿,2022,51(4):544-549.
JU L H,ZHAO L Y,FANG H Y,et al.Status of dietary micronutrient intakes among the children of 12-17 years old in China from 2016 to 2017£ÛJ£Ý.J Health Res,2022,51(4):544-549.
£Û19£Ý¡¡ÖìèñÓî,ÂÞåûåû,Ô¬Óñ·¼.Ë«à×´ïĪƬÁªºÏάÉúËØCÖÎÁÆС¶ù¹ýÃôÐÔ×Ïñ°¶ÔѪÇåTM¡¢PTX3¡¢IL-23µÄ±ä»¯Ñо¿£ÛJ£Ý.ºþÄÏʦ·¶´óѧѧ±¨(ҽѧ°æ),2022,19(1):118-121.
ZHU Y Y,LUO Y Y,YUAN Y F.Effect of dipyridamole tablets combined with vitamin C on serum TM,PTX3,IL-23 in children with Henoch-Schonlein purpura£ÛJ£Ý.J Hunan Normal Univ (Med Ed),2022,19(1):118-121.
ÏàËÆÎÄÏ×/References:
[1]¹ù×Óµî.С¼ÁÁ¿¸ÎËØÁªºÏ¼×ÇèßäëÒÖÎÁƹýÃôÐÔ×Ïñ°56 Àý[J].ÐÂÏçҽѧԺѧ±¨,2003,20(06):430.
[2]¹ù×Óµî.С¼ÁÁ¿¸ÎËØÁªºÏ¼×ÇèßäëÒÖÎÁƹýÃôÐÔ×Ïñ°56Àý[J].ÐÂÏçҽѧԺѧ±¨,2003,20(06):430.
[3]À÷ºé½,ÕÅÓ»Ô,Áõ´ä»ª,µÈ.Ѫ½¬Ñª¹ÜÄÚƤÉú³¤Òò×Ó¡¢Äò΢Á¿°×µ°°×¼°β2-΢Çòµ°°×Óë¹ýÃôÐÔ×Ïñ°»¼¶ùÔçÆÚÉöËðÉ˵ÄÏà¹ØÐÔ[J].ÐÂÏçҽѧԺѧ±¨,2008,25(02):173.
[4]ÅËЦÔÃ,Ñî´ïʤ,ÕԵ°²,µÈ. ¶ùͯ×Ïñ°ÐÔÉöÑ×Á÷Ðв¡Ñ§¡¢·¢²¡»úÖƼ°Ïà¹ØÉúÎïѧָ±êÑо¿½øÕ¹ [J].ÐÂÏçҽѧԺѧ±¨,2015,32(04):364.[doi:10.7683/xxyxyxb.2015.04.022]
[5]Ê·ÑóÑó,±ÏÁèÔÆ,Ñî´ïʤ.¶ùͯ×Ïñ°ÐÔÉöÑ׺ÍIgAÉö²¡µÄ·¢²¡»úÖƼ°²¡Àí·ÖÐÍÑо¿½øÕ¹[J].ÐÂÏçҽѧԺѧ±¨,2021,38(4):386.[doi:10.7683/xxyxyxb.2021.04.020]
[6]¹ùÇìÒú,¶¡¡¡Ó£,¹ù¡¡æÃ,µÈ.¶ùͯ¹ÂÁ¢ÐÔѪÄòÐÍ×Ïñ°ÐÔÉöÑ×135ÀýÁÙ´²·ÖÎö[J].ÐÂÏçҽѧԺѧ±¨,2018,35(6):531.[doi:10.7683/xxyxyxb.2018.06.021]
¡¡GUO Qing-yin,DING Ying,GUO Ting,et al.Analysis of the clinical features of isolated hematuria Henoch-Schonlein purpura nephritis of children in 135 cases[J].Journal of Xinxiang Medical University,2018,35(9):531.[doi:10.7683/xxyxyxb.2018.06.021]
[7]ÕÅÑÞÃô,ËÎÏþÏè,·âÆ仪.Ëû¿ËĪ˾ÖÎÁƶùͯ×Ïñ°ÐÔÉöÑ×ÁÆЧ¹Û²ì[J].ÐÂÏçҽѧԺѧ±¨,2017,34(9):815.[doi:10.7683/xxyxyxb.2017.09.009]
¡¡ZHANG Yan-min,SONG Xiao-xiang,FENG Qi-hua.Clinical effect of tacrolimus for Henoch-Sch¢‰nlein purpura nephritis in children[J].Journal of Xinxiang Medical University,2017,34(9):815.[doi:10.7683/xxyxyxb.2017.09.009]
[8]ÍõÀöÄÈ,·ëºìÑà,ÕÔ¡¡¼Ñ,µÈ.»ùÓÚÈýάÖÊÁ¿½á¹¹Ä£Ê½ÀíÂÛΪ¿ò¼ÜµÄÔºÍâÑÓÐøÐÔ»¤Àí¸ÉÔ¤¶Ô¹ýÃôÐÔ×Ïñ°»¼¶ù×ñÒ½ÐÐΪ¼°»¤ÀíÂúÒâ¶ÈµÄÓ°Ïì[J].ÐÂÏçҽѧԺѧ±¨,2017,34(10):949.[doi:10.7683/xxyxyxb.2017.10.022]
¡¡WANG Li-na,FENG Hong-yan,ZHAO Jia,et al.Effect of outside hospital continuing nursing intervention based on three-dimensional quality structure on compliance behavior and nursing satisfaction of children with henoch-schonlein purpura[J].Journal of Xinxiang Medical University,2017,34(9):949.[doi:10.7683/xxyxyxb.2017.10.022]